Oric Pharmaceuticals Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Oric Pharmaceuticals Inc's ROI in the second quarter of 2026?
Oric Pharmaceuticals Inc recorded a cumulative net loss of $-140 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -35.04%.

Within the Healthcare sector 395 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3409 to 3563.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Investment Change TTM	47.8 %	45.32 %	15.19 %	4.93 %	-4.22 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	384	419	388	411	329
Return On Investment (TTM)	-35.04 %	-34.96 %	-38.26 %	-44.56 %	-50.64 %
ORIC's Overall Ranking	# 3563	# 3409	# 2171	# 3429	# 3054
Seq. Investment Change TTM	3.56 %	14.31 %	11.46 %	12.01 %	1.83 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-140	-135	-129	-135	-137

ORIC Company Profile >> Back to ORIC Roi Comparisons >> See Annual ORIC Return On Investment

Return On Investment ORIC's Ranking
Within:	No.
Industry	# 154
Sector	# 396
Overall	# 3563

Return On Investment Statistics
High	Average	Low
-28.1 %	-38.5 %	-50.64 %
(Dec 31 2021)		(Jun 30 2025)

News about Oric Pharmaceuticals Inc Return on Investment ROI

ORIC Pharmaceuticals Prioritizes Talent Retention through Inducement Grants

June 7, 2024

Introduction
ORIC Pharmaceuticals, Inc., a pioneering clinical-stage oncology company, has recently announced the issuance of inducement grants as part of its steadfast commitment to oncology breakthroughs. The grants, which include non-qualified stock options and restricted stock units, serve as an incentive package to attract and retain top talent in the competitive field of oncology research. By aligning employee interests with the long-term growth and success of the company, ORIC aims to further its mission of developing innovative treatments that address mechanisms of therapeutic resistance.
Inducement Grants: Strengthening Workforce
On June 3, 2024, ORIC Pharmaceuticals granted a total of 30,000 non-qualified stock options and 4,800 restricted stock units to three new non-executive employees who joined the company in May 2024. This recent issuance of inducement grants follows a previous grant made on October 2, 2023, where ORIC awarded 72,120 non-qualified stock options and 12,040 restricted stock units to four new non-executive employees who started in September 2023.

Financial Statements
Oric Pharmaceuticals Inc's II. Quarter Investments	$ 384 Millions	ORIC's Balance sheet
Oric Pharmaceuticals Inc's II. Quarter Income	$ -41 Millions	Quarterly ORIC's Income Statement
ORIC's Income by Division		See ORIC's Income by Division

ORIC Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Investments in Millions	388	249	232	232	283
Y / Y Investment Growth	55.83 %	7.66 %	-0.1 %	-18.24 %	-2.24 %
Net Income in Millions	-129	-128	-101	-89	-79
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-33.33 %	-51.28 %	-43.49 %	-38.45 %	-27.77 %

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ORIC's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ORIC's Competitors
Subscribers only: Roi for Oric Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for ORIC's Customers

Other Ratios
ORIC's Roa	ORIC's Inventory Turnover Ratio	ORIC's Growth Rates	ORIC's Dividend Statistics
	ORIC's Profitability Ratios	ORIC's Asset Turnover Ratio	ORIC's Dividend Growth
ORIC's Roe	ORIC's Valuation Ratios	ORIC's Financial Strength Ratios	ORIC's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector

ROI

Date modified: 2026-09-12T18:47:46+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.